Study to Analyze the Metabolic Environment in Preventing Atopic Dermatitis

Overview

About this study

The purpose of this study is to compare the assessment of the composition of the fecal, nasal,oral and skin microbiota in patients with AD (cases) as compared to age/sex and diet matched control children without atopic dermatitis, and to apply mass-spectrometry-based metabolomic approach to analyzing fecal, nasal, oral and skin samples from cases, in order to characterize their biochemical metabolic profiles by comparison with those of their controls.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Cases:

  • Clinical diagnosis of atopic dermatitis (AD).
  • Age ≤ 2 years.

Inclusion Criteria - Controls:

  • No atopic dermatitis (AD).

Exclusion Criteria

  • Current systemic immunosuppression or oralantibiotics.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Avni Joshi, M.D., M.S.

Contact us for the latest status

Contact information:

Serina Stannard R.N., AE-C

Stannard.Serina@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20456757

Mayo Clinic Footer